13F reference period
Q2 2026
Security Snapshot
Allarity Therapeutics, Inc. - COM (ALLR) Institutional Ownership
CUSIP: 016744500
13F Institutional Holders and Ownership History from Q3 2024 to Q2 2026
Institutions Reporting
20
Shares (Excl. Options)
1.28M
Full value: 1,281,163 · shares · 30 Jun 2026Price
$1.29
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / COM
- Symbol
- ALLR on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 1,281,163
- Total 13F value
- $1,652,200
- Portfolio coverage rank
- 0%
- Share change
- +330,555
- Value change
- +$429,937
- Number of holders
- 20
- SEC-reported price per share
- $0.87
- Insider filing price
- $0.87
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- ALLR - Allarity Therapeutics, Inc. - COM is tracked under CUSIP 016744500.
- 20 institutions reported positions in Q2 2026.
- Schedule 13D/13G significant owner rows are not currently available.
Change
- Holder count moved from 14 to 20 between Q1 2026 and Q2 2026.
- SEC-reported value moved from to
$1.04M
Full value: $1,036,162 · USD · 31 Mar 2026.$1.65M
Full value: $1,652,200 · USD · 30 Jun 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 20 institutions filings for Q2 2026.
Security key
016744500
13F reference period
Q2 2026
13F holders
20
13D/G owners
0
CIK / CUSIP context first
Open Q2 2026 holders
ALLR full holder history
Allarity Therapeutics, Inc. SEC filings
Allarity Therapeutics, Inc. company facts
Allarity Therapeutics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 016744500:
As of 30 Jun 2026,
20
institutional investors reported holding
shares of
Allarity Therapeutics, Inc. - COM (ALLR).
1.28M
Full value: 1,281,163 · shares · 30 Jun 2026Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
8
Headline period
Q2 2026
Rows shown
1-8 of 8
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 1,281,163 | $1,652,200 | +$429,937 | $1.29 | 20 |
| 2026 Q1 | 950,608 | $1,036,162 | -$368,322 | $1.09 | 14 |
| 2025 Q4 | 1,292,104 | $1,395,296 | +$279,448 | $1.08 | 16 |
| 2025 Q3 | 1,033,190 | $1,632,439 | +$1,406,443 | $1.58 | 11 |
| 2025 Q2 | 195,090 | $197,041 | +$108,103 | $1.01 | 10 |
| 2025 Q1 | 92,361 | $86,090 | -$35,162 | $0.94 | 9 |
| 2024 Q4 | 104,487 | $122,250 | +$79,322 | $1.17 | 5 |
| 2024 Q3 | 21,866 | $46,137 | +$46,137 | $2.11 | 3 |